Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 21, 2024

BUY
$1.14 - $1.81 $1,635 - $2,597
1,435 Added 96.05%
2,929 $3,000
Q3 2023

Oct 30, 2023

BUY
$1.14 - $1.81 $1,635 - $2,597
1,435 Added 96.05%
2,929 $4,000
Q2 2023

May 21, 2024

SELL
$1.79 - $4.59 $75 - $192
-42 Reduced 2.73%
1,494 $2,000
Q2 2023

Jul 27, 2023

SELL
$1.79 - $4.59 $75 - $192
-42 Reduced 2.73%
1,494 $3,000
Q1 2023

May 21, 2024

BUY
$2.84 - $3.92 $2,019 - $2,787
711 Added 86.18%
1,536 $5,000
Q1 2023

Apr 27, 2023

BUY
$2.84 - $3.92 $2,019 - $2,787
711 Added 86.18%
1,536 $6,000
Q4 2022

May 21, 2024

BUY
$2.48 - $5.93 $2,046 - $4,892
825 New
825 $2,000
Q4 2022

Jan 31, 2023

BUY
$2.48 - $5.93 $193 - $462
78 Added 10.44%
825 $3,000
Q3 2022

Oct 21, 2022

BUY
$4.08 - $5.82 $3,047 - $4,347
747 New
747 $4,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $49.5M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.